Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling
International Journal of Molecular Sciences · 31.07.2023 · 24 (15) · 12237
DOI: 10.3390/ijms241512237 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.07.2023. Verfasst von Piotr Kmieć und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Medical University of Gdańsk, 80214 Gdańsk, Poland. Hauptthemen laut MEDLINE: Aldosterone, Transforming Growth Factor beta1, Ventricular Remodeling. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Angiotensin II, a major culprit in cardiovascular disease, activates mediators that are also involved in pathological cardiac remodeling. In this context, we aimed at investigating the effects of two of them: aldosterone (Ald) and transforming growth factor beta-1 (TGF-β1) in an in vivo model. Six-week-old male wild-type (WT) and TGF-β1-overexpressing transgenic (TGF-β1-TG) mice were infused with subhypertensive doses of Ald for 2 weeks and/or treated orally with eplerenone from postnatal day 21. Thehearts’ ventricles were examined by morphometry, immunoblotting to assess the intracellular signaling pathways and RT qPCR to determine hypertrophy and fibrosis marker genes. The TGF-β1-TG mice spontaneously developed cardiac hypertrophy and interstitial fibrosis and exhibited a higher baseline phosphorylation of p44/42 and p38 kinases, fibronectin and ANP mRNA expression. Ald induced a comparable increase in the ventricular-heart-weight-to-body-weight ratio and cardiomyocyte diameter in both strains, but a less pronounced increase in interstitial fibrosis in the transgenic compared to the WT mice (23.6% vs. 80.9%, p < 0.005). Ald increased the phosphorylation of p44/42 and p38 in the WT but not the TGF-β1-TG mice. While the eplerenone-enriched chow partially prevented Ald-induced cardiac hypertrophy in both genotypes and interstitial fibrosis in the WT controls, it completely protected against additional fibrosis in transgenic mice. Ald appears to induce cardiac hypertrophy independently of TGF-β1, while in the case of fibrosis, the downstream signaling pathways of these two factors probably converge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Internal Medicine, Medical University of Gdańsk, 80214 Gdańsk, Poland.
- Clinic for Internal Medicine III and Cologne Cardiovascular Research Center, Cologne University Heart Center, 50937 Köln, Germany.
- Institute of Pathology, University Hospital of Cologne and Center for Molecular Medicine, University of Cologne, 50937 Köln, Germany.
- Department of Cardiology, University-Medicine Rostock, 18057 Rostock, Germany.
ORCID-Profile: Piotr Kmieć, Margarete Odenthal, Evren Caglayan
Zitieren
APA
Kmieć, P., Rosenkranz, S., Odenthal, M., & Caglayan, E. (2023). Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling. International Journal of Molecular Sciences, 24(15), 12237. https://doi.org/10.3390/ijms241512237
Vancouver
Kmieć P, Rosenkranz S, Odenthal M, Caglayan E. Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling. International Journal of Molecular Sciences. 2023;24(15):12237. doi:10.3390/ijms241512237
BibTeX
@article{Kmie2023,
author = {Kmieć, Piotr and Rosenkranz, Stephan and Odenthal, Margarete and Caglayan, Evren},
title = {Differential Role of Aldosterone and Transforming Growth Factor Beta-1 in Cardiac Remodeling},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {15},
pages = {12237},
doi = {10.3390/ijms241512237}
}
EUVIMED